NFE2L2 and cancer: Indeed, a variety of cancers exhibit hyperactivation of Nrf2, conferring aggressive proliferation (Okazaki et al., 2020), metastasis (Lignitto et al., 2019), chemoresistance (Jeong et al., 2020), and radioresistance (Wang Z. et al., 2020).